arrow
J

Julio Santoyo Santoyo

complejo hospitalario universitario a coruna
H指数:21
被引数:3,087

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of Volume on Postoperative Outcomes After Left Pancreatectomy: A Multicenter Prospective Snapshot Study (SPANDISPAN Project)

左胰腺切除术后结局的容量效应:一项多中心前瞻性快照研究(SPANDISPAN项目)

2026-03-030
OA
Surgical approach and postoperative outcomes after left pancreatectomy (SPANDISPAN prospective project)

左胰腺切除术的手术入路及术后结果(SPANDISPAN前瞻性研究项目)

2025-09-010
PRE
Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis

复杂门静脉血栓形成肝移植受者的门静脉血运重建的替代形式

2023-04-0110
OAAI
Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

循环确定死亡肝移植后控制性捐献的腹部常温区域灌注: 移植物丢失的结果和危险因素

2022-04-0190
PRE
Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy? A Multicenter, Randomized, Controlled Trial
2019-11-0142
PREAI
Reply to: ormothermic regional perfusion - What is the benefit?''
2019-08-014
OAAI
The UK DCD Risk Score: Still no consensus on futility in DCD liver transplantation
2019-05-013
OAAI
Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation

正常体温区域灌注vs。循环死亡肝移植后控制性捐献的超快速恢复

2019-04-01185
PREAI
The Southampton Consensus Guidelines for Laparoscopic Liver Surgery From Indication to Implementation

南安普敦腹腔镜肝脏手术共识指南从适应症到实施

2018-07-01523
OAAI
Superior Outcomes Using Normothermic Regional Perfusion in CDCD Liver Transplantation
2018-07-012
PREAI
FNDC5 could be regulated by leptin in adipose tissue
2014-09-0340
PREAI
Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Patients Undergoing Liver Transplantation
2014-05-01147
PREAI
Very Early'' Intrahepatic Cholangiocarcinoma in Cirrhotic Patients: Should Liver Transplantation Be Reconsidered in These Patients?
2014-03-01138
OAAI
INTRAHEPATIC CHOLANGIOCARCINOMA (I-CC) OR MIXED HEPATOCELLULAR-CHOLANGIOCARCINOMA (HCC-CC) IN PATIENTS UNDERGOING LIVER TRANSPLANTATION. A SPANISH CASE CONTROL MULTICENTER STUDY
2013-04-011
OAAI